By The Online Investor Staff, updated Thu., Jul. 27, 8:52 PM
Slide #1. Sienna Biopharmaceuticals, Inc. — Initial Public Offering
||Sienna Biopharmaceuticals, Inc.
|Price Per Share:
||Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) today announced the pricing of the Company's initial public offering of 4,333,333 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts. All of the shares of common stock are being offered by Sienna. The Company has also granted the underwriters a 30-day option to purchase from the Company an additional 650,000 shares of common stock at the initial public offering price, less the underwriting discount. Sienna's common stock has been approved for listing on The NASDAQ Global Select Market and is expected to begin trading under the ticker symbol "SNNA" on July 27, 2017. The offering is expected to close on Aug. 1, 2017, subject to customary closing conditions.
IPOs: Sienna Biopharmaceuticals, Inc.
List of IPOs in this Slideshow:
Company Ticker IPO Date
Esquire Financial Holdings, Inc. ESQ
Blue Apron Holdings, Inc. APRN
Aileron Therapeutics, Inc. ALRN
Dova Pharmaceuticals, Inc. DOVA
Byline Bancorp, Inc. BY
Tintri, Inc. TNTR
Akcea Therapeutics, Inc. AKCA
TPG RE Finance Trust, Inc TRTX
Calyxt, Inc. CLXT
Kala Pharmaceuticals, Inc. KALA
Osprey Energy Acquisition Corp. OSPRU
PetIQ, Inc. PETQ
RBB Bancorp RBB
Industrea Acquisition Corp. INDU
Sienna Biopharmaceuticals, Inc. SNNA
July 27, 2017 8:52 PM Eastern